|Heather Manchin Bresch|
Heather Bresch testifying before the United States House Committee on Energy and Commerce in 2012.
|Alma mater||West Virginia University|
|Occupation||Chief executive officer|
Bresch's has been Mylan's president, chief operating officer, head of North American operations and chief integration officer. She joined Mylan's Board of Directors in March 2011. She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of generic drugs and appeared before a special United States Senate committee on the issue in 2006 and again in 2009. Bresch also testified before the Food and Drug Administration in September 2010 on the issue of generic drug user fees, proposing a new user fee structure that aims to generate more funding for the FDA and provide greater assurance for pharmaceutical product safety, regardless of where in the world the product or its ingredients come from. On February 9, 2012, Bresch testified before the U.S. House of Representatives' Committee on Energy and Commerce in relation to drug supply chain integrity, drug shortages and the Generic Industry's Drug User Fee proposal (GDUFA).
Bresch was named one of Fortune's "50 Most Powerful Women In Business"  in 2012 and 2013. In 2011, Bresch was named a Patriot of the Year by Esquire Magazine for her work which led to the passage of the FDA Safety and Innovation Act - legislation which will require foreign drugmakers that sell product in the U.S. to pay for regular facility inspections to support the FDA's efforts to continue ensuring drug safety for all U.S. consumers. Also in 2011, Bresch was named one of Pharmaceutical Executive's "Emerging Pharma Leaders 2011." In 2009, Bresch was named one of the top women in the global pharmaceutical industry by FiercePharma.
||It has been suggested that this article be merged with Heather Bresch M.B.A. controversy. (Discuss) Proposed since January 2015.|
Bresch is the daughter of West Virginia U.S. Senator and former West Virginia governor Joe Manchin. She received her undergraduate degree from West Virginia University. She was then an MBA student at West Virginia University until 1998. In 2007, the Pittsburgh Post-Gazette reported that Bresch said she had an MBA degree from West Virginia University. The university did have such a record, but soon after awarded her the MBA; she was missing 22 of the 48 credits in the program. After a report commissioned by the university, the university announced in April 2008 that it would rescind Bresch's degree.
- “Robert Cindrich, Heather Bresch named to Mylan board”, Pittsburgh Business Times, 1 March 2011
- "Mylan Calls for End to Abusive Practices That Delay Access to Affordable Pharmaceuticals", PR Newswire, 20 July 2006, accessed 2008-04-24
- "Mylan testifies before Senate special committee on aging", Observer-Reporter (Washington, PA), 21 July 2006, accessed on 2008-04-24
- Brent Kendall, "Lawmakers, Drug Makers Spar Over Patent Settlements", Wall Street Journal, 3 June 2009
- "Esquire's Americans of the Year: Patriots", Esquire Magazine, 19 November 2011, accessed 2012-01-31
- "Heather Bresch - Top 15 Women in Pharma”, FiercePharma 12 Oct. 2009
- Len Boselovic and Patricia Sabatini, "University revokes degree after scathing report on M.B.A. awarded to Bresch", Pittsburgh Post-Gazette, 24 April 2008, accessed 2008-04-24